Citation Impact
Citing Papers
Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies
2015
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Rodent-borne diseases and their risks for public health
2009 Standout
Immunotherapy of cancer in 2012
2012
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Duration of Red-Cell Storage and Complications after Cardiac Surgery
2008 Standout
An immune edited tumour versus a tumour edited immune system: prospects for immune therapy of acute myeloid leukaemia
2006
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Clinical Trials of Cancer Therapies Targeting Prostate-Specific Membrane Antigen
2007
Risk for postoperative infection after transfusion of white blood cell–filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty
2004
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Immunology and immunotherapy approaches for prostate cancer
2007
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects
2003
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen
2005
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
2006 StandoutNobel
Association of mortality with age of blood transfused in septic ICU patients
1997
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Transfusion Medicine — Blood Transfusion
1999 Standout
DNA vaccines: ready for prime time?
2008
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems
2004 StandoutNobel
Antibody therapy of cancer
2012 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Effect of perioperative blood transfusions on recurrence of colorectal cancer
1998
Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
2010 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*
2004 Standout
Radiation as Immunomodulator: Implications for Dendritic Cell-Based Immunotherapy
2014
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
B7-1 Overexpression by Thymic Epithelial Cells Results in Transient and Long-Lasting Effects on Thymocytes and Peripheral T Helper Cells but Does Not Result in Immunodeficiency
1999
Immunotherapy for prostate cancer
2006
Resolution of inflammation: the beginning programs the end
2005 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Risks associated with transfusion of cellular blood components in canada
2003
Emerging zoonoses and vector-borne infections affecting humans in Europe
2007
Checkpoint Blockade in Cancer Immunotherapy
2006 StandoutNobel
Antibody and T‐cell responses specific for the androgen receptor in patients with prostate cancer
2007
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
2014
Microneedles for drug and vaccine delivery
2012 Standout
Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells
2005 StandoutNobel
Transfusion-related immunomodulation (TRIM): An update
2007
Human Tularemia in France, 2006-2010
2011
Nanoparticle and targeted systems for cancer therapy
2004 Standout
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
2020 Standout
Human Clinical Trials of Plasmid DNA Vaccines
2005
Immunotherapy for prostate cancer
2007
Characterization and Activity of Fas Ligand Producing CD5+ B Cells
2014
Anemia of Chronic Disease
2005 Standout
Transfusion‐related immunomodulation: a second hit in an inflammatory cascade?
2008
Pneumonia as a complication of blood product transfusion in the critically ill: Transfusion-related immunomodulation (TRIM)
2006
The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
2018
Universal WBC reduction:the case for and against
2001
Intratumoral Injection of DNA Encoding Human Interleukin 12 into Patients with Metastatic Melanoma: Clinical Efficacy
2005
Safety, Tolerability, and Lack of Antibody Responses After Administration of a Pf CSP DNA Malaria Vaccine via Needle or Needle-Free Jet Injection, and Comparison of Intramuscular and Combination Intramuscular/Intradermal Routes
2002
DNA Vaccines—How Far From Clinical Use?
2018
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Current Developments in Cancer Vaccines and Cellular Immunotherapy
2003
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
2007 StandoutNobel
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Biologic effects of leukocytes present in transfused cellular blood products
1994
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
Perioperative blood transfusions for the recurrence of colorectal cancer
2004
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
2009 Standout
Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor Immunity
2006 StandoutNobel
Phagocytosis Triggers Macrophage Release of Fas Ligand and Induces Apoptosis of Bystander Leukocytes
1999
Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice.
2001
Next Generation of Immunotherapy for Melanoma
2008
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
Immunization With Mutantp53- andK-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome
2005
Cancer Genome Landscapes
2013 StandoutScience
Absence of Programmed Death Receptor 1 Alters Thymic Development and Enhances Generation of CD4/CD8 Double-Negative TCR-Transgenic T Cells
2003 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Prosthetic Joint Infection
2014 Standout
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
2001
Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier
2003
Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook
2008
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Works of Milcho Mincheff being referenced
Human dendritic cells genetically engineered to express cytosolically retained fragment of prostate-specific membrane antigen prime cytotoxic T-cell responses to multiple epitopes
2003
An Alternative Mechanism for the Immunosuppressive Effect of Transfusion
2002
Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I/II Clinical Trial
2000
Changes in Donor Leukocytes during Blood Storage. Implications on Post‐ Transfusion Immunomodulation and Transfusion‐Associated GVHD
1998
Blood Transfusion, Blood Storage and Immunomodulation
1995
Blood Transfusion and Immunomodulation: A Possible Mechanism
1993
COSTIMULATORY SIGNALS NECESSARY FOR INDUCTION OF T CELL PROLIFERATION
1990
In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer—changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-γ lymphokine profile
2001
Fas and Fas Ligand Expression on Human Peripheral Blood Leukocytes
1998
Fas and Fas Ligand Expression on Human Peripheral Blood Leukocytes
1998
MECHANISMS OF ALLOIMMUNIZATION AND IMMUNOSUPPRESSION BY BLOOD TRANSFUSIONS IN AN INBRED RODENT MODEL
1995
Tularemia Outbreak, Bulgaria, 1997–2005
2006
Cancer vaccines 2004 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoediting.
2005